Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $641,940 |
Sells | 126 | $5,108,688 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 27 Sep 2022 | Sale | 2,403 | 15.3096 | 36,789 | D |
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Sep 2022 | Sale | 300 | 16.33 | 4,899 | D |
28 Sep 2022 17:10 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 26 Sep 2022 | Sale | 2,768 | 15.2206 | 42,131 | D |
28 Sep 2022 17:08 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 26 Sep 2022 | Sale | 215 | 16.2477 | 3,493 | D |
28 Sep 2022 17:08 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 26 Sep 2022 | Sale | 1,329 | 15.32 | 20,360 | D |
23 Sep 2022 16:59 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 23 Sep 2022 | Sale | 1,023 | 15.066 | 15,413 | D |
23 Sep 2022 16:59 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 21 Sep 2022 | Sale | 3,402 | 15.1162 | 51,425 | D |
23 Sep 2022 16:57 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 23 Sep 2022 | Sale | 939 | 15.0871 | 14,167 | D |
23 Sep 2022 16:57 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 21 Sep 2022 | Sale | 3,341 | 15.0833 | 50,393 | D |
23 Sep 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 23 Sep 2022 | Sale | 1,018 | 15.0694 | 15,341 | D |
23 Sep 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 21 Sep 2022 | Sale | 3,275 | 15.1258 | 49,537 | D |
19 Sep 2022 16:35 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 15 Sep 2022 | Sale | 200 | 15.04 | 3,008 | D |
19 Sep 2022 16:34 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 15 Sep 2022 | Sale | 100 | 15.01 | 1,501 | D |
19 Sep 2022 16:32 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 15 Sep 2022 | Sale | 106 | 15.0134 | 1,591 | D |
12 Sep 2022 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 09 Sep 2022 | Sale | 688 | 15.0669 | 10,366 | D |
12 Sep 2022 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 08 Sep 2022 | Sale | 1,100 | 15.1577 | 16,673 | D |
12 Sep 2022 16:18 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 09 Sep 2022 | Sale | 800 | 15.0669 | 12,054 | D |
12 Sep 2022 16:18 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 08 Sep 2022 | Sale | 1,221 | 15.1333 | 18,478 | D |
12 Sep 2022 16:14 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 09 Sep 2022 | Sale | 865 | 15.0646 | 13,031 | D |
12 Sep 2022 16:14 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 08 Sep 2022 | Sale | 912 | 15.1472 | 13,814 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 31 Aug 2022 | Sale | 171 | 12 | 2,052 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 30 Aug 2022 | Sale | 190 | 12 | 2,280 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 25 | 14 | 350 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 505 | 13.5097 | 6,822 | D |
31 Aug 2022 16:55 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 29 Aug 2022 | Sale | 1,109 | 12.5615 | 13,931 | D |
26 Aug 2022 16:06 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 25 Aug 2022 | Sale | 1,551 | 14.1754 | 21,986 | D |
26 Aug 2022 16:06 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 24 Aug 2022 | Sale | 301 | 14.227 | 4,282 | D |
26 Aug 2022 16:06 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 24 Aug 2022 | Sale | 2,817 | 13.5226 | 38,093 | D |
23 Aug 2022 18:28 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 23 Aug 2022 | Sale | 2,909 | 13.0903 | 38,080 | D |
23 Aug 2022 18:28 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Aug 2022 | Sale | 217 | 13.0047 | 2,822 | D |
23 Aug 2022 18:28 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 19 Aug 2022 | Sale | 8,529 | 13.0766 | 111,530 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 18 Aug 2022 | Sale | 200 | 13 | 2,600 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 17 Aug 2022 | Sale | 200 | 13.07 | 2,614 | D |
18 Aug 2022 18:53 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 16 Aug 2022 | Sale | 200 | 13 | 2,600 | D |
29 Jul 2022 16:03 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Jul 2022 | Sale | 2,000 | 12 | 24,000 | D |
29 Jun 2022 16:02 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 27 Jun 2022 | Sale | 7,714 | 13 | 100,282 | D |
29 Jun 2022 16:02 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Jun 2022 | Sale | 4,000 | 12 | 48,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)